GSE197555 1 V 2 TRAMETINIB HUMAN DN (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE197555 1 V 2 TRAMETINIB HUMAN DN.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE197555 1 V 2 TRAMETINIB HUMAN DN.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE197555 1 V 2 TRAMETINIB HUMAN DN.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE197555 1 V 2 TRAMETINIB HUMAN DN.

Results found

Linked to

 

Label

Description

 

Gene

ARPIN-AP3S2 readthrough

Gene

CDGSH iron sulfur domain 3

Gene

contactin associated protein family member 3C

Gene

TATA-box binding protein associated factor 11 like 11

Gene

SLCO1B3-SLCO1B7 readthrough

Gene

solute carrier family 52 member 2

Gene

myosin XVB

Gene

haloacid dehalogenase like hydrolase domain containing 3

Gene

kelch domain containing 7A

Gene

ankyrin repeat and LEM domain containing 2

  • Gene

    ARPIN-AP3S2 readthrough


  • Gene

    CDGSH iron sulfur domain 3


  • Gene

    contactin associated protein family member 3C


  • Gene

    TATA-box binding protein associated factor 11 like 11


  • Gene

    SLCO1B3-SLCO1B7 readthrough


  • Gene

    solute carrier family 52 member 2



  • Gene

    haloacid dehalogenase like hydrolase domain containing 3


  • Gene

    kelch domain containing 7A


  • Gene

    ankyrin repeat and LEM domain containing 2

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.